Adaptive Biotechnologies Corporation (ADPT)’s liquidity ratios and what they mean

The price of Adaptive Biotechnologies Corporation (NASDAQ: ADPT) closed at $6.37 in the last session, up 1.43% from day before closing price of $6.28. In other words, the price has increased by $+0.09 from its previous closing price. On the day, 1154266 shares were traded. ADPT stock price reached its highest trading level at $6.58 during the session, while it also had its lowest trading level at $6.14.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.



We take a closer look at ADPT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.30 and its Current Ratio is at 5.60. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.30.

Upgrades & Downgrades

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 11 when ADAMS R MARK sold 2,308 shares for $8.63 per share. The transaction valued at 19,918 led to the insider holds 175,361 shares of the business.

ADAMS R MARK sold 817 shares of ADPT for $6,944 on Apr 10. The Chief Operating Officer now owns 177,669 shares after completing the transaction at $8.50 per share. On Mar 27, another insider, GRIFFIN MICHELLE RENEE, who serves as the Director of the company, sold 2,341 shares for $8.49 each. As a result, the insider received 19,878 and left with 20,627 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADPT now has a Market Capitalization of 920.95M and an Enterprise Value of 586.03M. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.92 while its Price-to-Book (P/B) ratio in mrq is 2.16. Its current Enterprise Value per Revenue stands at 3.18 whereas that against EBITDA is -3.53.

Stock Price History:

Over the past 52 weeks, ADPT has reached a high of $13.21, while it has fallen to a 52-week low of $5.95. The 50-Day Moving Average of the stock is 7.71, while the 200-Day Moving Average is calculated to be 8.37.

Shares Statistics:

According to the various share statistics, ADPT traded on average about 846.37K shares per day over the past 3-months and 890.54k shares per day over the past 10 days. A total of 143.51M shares are outstanding, with a floating share count of 140.66M. Insiders hold about 0.20% of the company’s shares, while institutions hold 89.30% stake in the company. Shares short for ADPT as of Apr 27, 2023 were 6.09M with a Short Ratio of 6.09M, compared to 6.12M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 4.22% and a Short% of Float of 6.19%.

Earnings Estimates

The company has 10 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.35 for the current quarter, with a high estimate of -$0.3 and a low estimate of -$0.38, while EPS last year was -$0.37. The consensus estimate for the next quarter is -$0.28, with high estimates of -$0.25 and low estimates of -$0.32.

Analysts are recommending an EPS of between -$1.12 and -$1.32 for the fiscal current year, implying an average EPS of -$1.23. EPS for the following year is -$1.01, with 10 analysts recommending between -$0.69 and -$1.34.

Revenue Estimates

According to 9 analysts, the current quarter’s revenue is expected to be $45.04M. It ranges from a high estimate of $47.5M to a low estimate of $42M. As of the current estimate, Adaptive Biotechnologies Corporation’s year-ago sales were $43.66M, an estimated increase of 3.20% from the year-ago figure. For the next quarter, 9 analysts are estimating revenue of $54.21M, an increase of 12.90% over than the figure of $3.20% in the same quarter last year. There is a high estimate of $59.4M for the next quarter, whereas the lowest estimate is $51.12M.

A total of 10 analysts have provided revenue estimates for ADPT’s current fiscal year. The highest revenue estimate was $210.01M, while the lowest revenue estimate was $203.5M, resulting in an average revenue estimate of $207.57M. In the same quarter a year ago, actual revenue was $185.31M, up 12.00% from the average estimate. Based on 10 analysts’ estimates, the company’s revenue will be $260.74M in the next fiscal year. The high estimate is $281.9M and the low estimate is $237.75M. The average revenue growth estimate for next year is up 25.60% from the average revenue estimate for this year.